Trial Profile
The effect of landiolol on rehospitalization for heart failure in patients with acute heart failure and atrial fibrillation
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2019
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
- 28 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Aug 2016 Status changed from not yet recruiting to recruiting.
- 17 May 2016 New trial record